Innoforce Pharmaceuticals

Innoforce Pharmaceuticals

Signal active

Organization

Contact Information

Overview

Innoforce is a biopharma manufacturing firm that facilitates the development and commercialization of innovative medicines.

About

Industries

Biotechnology, Health Care, Pharmaceutical, Manufacturing, Biopharma

Founded

2018

Employees

101-250

Headquarters locations

Asia

Social

N/A

Profile Resume

Innoforce Pharmaceuticals headquartered in Asia, operates in the Biotechnology, Health Care, Pharmaceutical, Manufacturing, Biopharma sector. The company focuses on Biotechnology and has secured $6.2B in funding across 40 round(s). With a team of 101-250 employees, Innoforce Pharmaceuticals is actively contributing to advancements in Biotechnology. Their latest funding round, Series A - Innoforce Pharmaceuticals, raised $58.8M. Discover more about their projects, partnerships, and impact on our platform.

Employees

N/A

Funding Rounds

Funding rounds

2

Investors

9

Lead Investors

0

Total Funding Amount

$154.9M

Details

2

Innoforce Pharmaceuticals has raised a total of $154.9M in funding over 2 rounds.

Announcement dateTransaction nameNumber of InvestorsMoney raisedLead Investor
2021Early Stage Venture96.0M
2021Early Stage Venture58.8M

Investors

Innoforce Pharmaceuticals is funded by 13 investors.

Investor NameLead InvestorFunding RoundPartners
Liu Zeng-FUNDING ROUND - Liu Zeng58.8M
Innoforce Pharmaceuticals-FUNDING ROUND - Innoforce Pharmaceuticals58.8M
China Highrun Capital Limited-FUNDING ROUND - China Highrun Capital Limited58.8M
Innoforce Pharmaceuticals-FUNDING ROUND - Innoforce Pharmaceuticals58.8M

Recent Activity

There is no recent news or activity for this profile.